You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CYTK Exercise Disclosure
Callos Andrew · SEC Form 4 · Filed Jul 30, 2026
Exercise
Calculated transaction value
$0
Callos Andrew EVP, Chief Commercial Officer
CYTK
Cytokinetics Inc
CYTK
Transaction date
Jul 30, 2026
Public filing date
Jul 30, 2026
Filing lag
Filed same day
CYTK daily price context
Close on/before transaction
$80.42
Jul 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 14,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001061983-26-000086
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.44M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytokinetics Inc CYTK | Exercise | Jul 30, 2026 | $325.64K |
| Cytokinetics Inc CYTK | Sale | Jul 30, 2026 | $1.12M |
| Cytokinetics Inc CYTK Current | Exercise | Jul 30, 2026 | $0 |